Canakinumab Subcutaneous and Mydriacyl Ophthalmic
Determining the interaction of Canakinumab Subcutaneous and Mydriacyl Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: tropicamide ophthalmic
Brand name: Mydriacyl, Tropicacyl, Opticyl, Mydral, Ocu-Tropic
Synonyms: Mydriacyl
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Myferon 150
- Canakinumab Subcutaneous-Myferon 150 Forte
- Canakinumab Subcutaneous-Myfortic
- Canakinumab Subcutaneous-MyHist-PD
- Canakinumab Subcutaneous-MyKidz Iron
- Canakinumab Subcutaneous-MyKidz Iron 10
- Mydriacyl Ophthalmic-Canasa
- Mydriacyl Ophthalmic-Canasa Pac rectal
- Mydriacyl Ophthalmic-Canasa rectal
- Mydriacyl Ophthalmic-Cancidas
- Mydriacyl Ophthalmic-Candesartan
- Mydriacyl Ophthalmic-Candesartan and Hydrochlorothiazide